The global Preclinical Toxicology Testing Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Preclinical Toxicology Testing Services are a set of laboratory and research services conducted to assess the safety and potential toxicity of new drugs, chemicals, medical devices, or other substances before they are tested in humans in clinical trials. These services are an essential part of the drug development and regulatory approval process and are typically required by regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to ensure the safety and efficacy of new pharmaceutical and chemical compounds.
The global preclinical toxicology testing services market is significant and has experienced steady growth in recent years. It is driven by the continuous development of new pharmaceuticals, chemicals, and medical devices, as well as increasing regulatory scrutiny. The United States is a major hub for preclinical toxicology testing services, with a well-established pharmaceutical and biotechnology industry. Regulatory requirements from the FDA drive the demand for toxicology testing. Countries within the European Union also have significant demand for preclinical toxicology testing due to the robust pharmaceutical industry. Regulatory bodies like the European Medicines Agency (EMA) require safety assessments for market approval. The Asia-Pacific region is experiencing substantial growth in preclinical toxicology testing services, particularly in countries like China and India, where the pharmaceutical and chemical industries are expanding rapidly.
The 鈥淧reclinical Toxicology Testing Service Industry Forecast鈥� looks at past sales and reviews total world Preclinical Toxicology Testing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Preclinical Toxicology Testing Service sales for 2025 through 2031. With Preclinical Toxicology Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preclinical Toxicology Testing Service industry.
This Insight Report provides a comprehensive analysis of the global Preclinical Toxicology Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Preclinical Toxicology Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Preclinical Toxicology Testing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preclinical Toxicology Testing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preclinical Toxicology Testing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Preclinical Toxicology Testing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
In Vitro Toxicology Testing
In Vivo Toxicology Testing
Segmentation by Application:
Biopharmaceutical Company
Research Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent
Abbott
Bio-Rad
Scantox
Charles River
Bioreliance
Catalent
INVITEK Inc.
Altogen Labs
Pacific BioLabs
AmplifyBio
Altasciences
Evotec
Eurofins Scientific
Pharmaron
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Preclinical Toxicology Testing Service 麻豆原创 Size (2020-2031)
2.1.2 Preclinical Toxicology Testing Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Preclinical Toxicology Testing Service by Country/Region (2020, 2024 & 2031)
2.2 Preclinical Toxicology Testing Service Segment by Type
2.2.1 In Vitro Toxicology Testing
2.2.2 In Vivo Toxicology Testing
2.3 Preclinical Toxicology Testing Service 麻豆原创 Size by Type
2.3.1 Preclinical Toxicology Testing Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Preclinical Toxicology Testing Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Preclinical Toxicology Testing Service Segment by Application
2.4.1 Biopharmaceutical Company
2.4.2 Research Laboratory
2.4.3 Others
2.5 Preclinical Toxicology Testing Service 麻豆原创 Size by Application
2.5.1 Preclinical Toxicology Testing Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Preclinical Toxicology Testing Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Preclinical Toxicology Testing Service 麻豆原创 Size by Player
3.1 Preclinical Toxicology Testing Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Preclinical Toxicology Testing Service Revenue by Player (2020-2025)
3.1.2 Global Preclinical Toxicology Testing Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Preclinical Toxicology Testing Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Preclinical Toxicology Testing Service by Region
4.1 Preclinical Toxicology Testing Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Preclinical Toxicology Testing Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Preclinical Toxicology Testing Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Preclinical Toxicology Testing Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Preclinical Toxicology Testing Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Preclinical Toxicology Testing Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Preclinical Toxicology Testing Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Preclinical Toxicology Testing Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preclinical Toxicology Testing Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Preclinical Toxicology Testing Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Preclinical Toxicology Testing Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Preclinical Toxicology Testing Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Preclinical Toxicology Testing Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Preclinical Toxicology Testing Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Preclinical Toxicology Testing Service by Region (2020-2025)
8.2 Middle East & Africa Preclinical Toxicology Testing Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Preclinical Toxicology Testing Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Preclinical Toxicology Testing Service 麻豆原创 Forecast
10.1 Global Preclinical Toxicology Testing Service Forecast by Region (2026-2031)
10.1.1 Global Preclinical Toxicology Testing Service Forecast by Region (2026-2031)
10.1.2 Americas Preclinical Toxicology Testing Service Forecast
10.1.3 APAC Preclinical Toxicology Testing Service Forecast
10.1.4 Europe Preclinical Toxicology Testing Service Forecast
10.1.5 Middle East & Africa Preclinical Toxicology Testing Service Forecast
10.2 Americas Preclinical Toxicology Testing Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.2.2 Canada 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.2.3 Mexico 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.2.4 Brazil 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.3 APAC Preclinical Toxicology Testing Service Forecast by Region (2026-2031)
10.3.1 China Preclinical Toxicology Testing Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.3.3 Korea 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.3.4 Southeast Asia 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.3.5 India 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.3.6 Australia 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.4 Europe Preclinical Toxicology Testing Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.4.2 France 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.4.3 UK 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.4.4 Italy 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.4.5 Russia 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.5 Middle East & Africa Preclinical Toxicology Testing Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.5.2 South Africa 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.5.3 Israel 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.5.4 Turkey 麻豆原创 Preclinical Toxicology Testing Service Forecast
10.6 Global Preclinical Toxicology Testing Service Forecast by Type (2026-2031)
10.7 Global Preclinical Toxicology Testing Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Preclinical Toxicology Testing Service Forecast
11 Key Players Analysis
11.1 Agilent
11.1.1 Agilent Company Information
11.1.2 Agilent Preclinical Toxicology Testing Service Product Offered
11.1.3 Agilent Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Agilent Main Business Overview
11.1.5 Agilent Latest Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Preclinical Toxicology Testing Service Product Offered
11.2.3 Abbott Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Abbott Main Business Overview
11.2.5 Abbott Latest Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Information
11.3.2 Bio-Rad Preclinical Toxicology Testing Service Product Offered
11.3.3 Bio-Rad Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Bio-Rad Main Business Overview
11.3.5 Bio-Rad Latest Developments
11.4 Scantox
11.4.1 Scantox Company Information
11.4.2 Scantox Preclinical Toxicology Testing Service Product Offered
11.4.3 Scantox Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Scantox Main Business Overview
11.4.5 Scantox Latest Developments
11.5 Charles River
11.5.1 Charles River Company Information
11.5.2 Charles River Preclinical Toxicology Testing Service Product Offered
11.5.3 Charles River Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Charles River Main Business Overview
11.5.5 Charles River Latest Developments
11.6 Bioreliance
11.6.1 Bioreliance Company Information
11.6.2 Bioreliance Preclinical Toxicology Testing Service Product Offered
11.6.3 Bioreliance Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Bioreliance Main Business Overview
11.6.5 Bioreliance Latest Developments
11.7 Catalent
11.7.1 Catalent Company Information
11.7.2 Catalent Preclinical Toxicology Testing Service Product Offered
11.7.3 Catalent Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Catalent Main Business Overview
11.7.5 Catalent Latest Developments
11.8 INVITEK Inc.
11.8.1 INVITEK Inc. Company Information
11.8.2 INVITEK Inc. Preclinical Toxicology Testing Service Product Offered
11.8.3 INVITEK Inc. Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 INVITEK Inc. Main Business Overview
11.8.5 INVITEK Inc. Latest Developments
11.9 Altogen Labs
11.9.1 Altogen Labs Company Information
11.9.2 Altogen Labs Preclinical Toxicology Testing Service Product Offered
11.9.3 Altogen Labs Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Altogen Labs Main Business Overview
11.9.5 Altogen Labs Latest Developments
11.10 Pacific BioLabs
11.10.1 Pacific BioLabs Company Information
11.10.2 Pacific BioLabs Preclinical Toxicology Testing Service Product Offered
11.10.3 Pacific BioLabs Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Pacific BioLabs Main Business Overview
11.10.5 Pacific BioLabs Latest Developments
11.11 AmplifyBio
11.11.1 AmplifyBio Company Information
11.11.2 AmplifyBio Preclinical Toxicology Testing Service Product Offered
11.11.3 AmplifyBio Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 AmplifyBio Main Business Overview
11.11.5 AmplifyBio Latest Developments
11.12 Altasciences
11.12.1 Altasciences Company Information
11.12.2 Altasciences Preclinical Toxicology Testing Service Product Offered
11.12.3 Altasciences Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Altasciences Main Business Overview
11.12.5 Altasciences Latest Developments
11.13 Evotec
11.13.1 Evotec Company Information
11.13.2 Evotec Preclinical Toxicology Testing Service Product Offered
11.13.3 Evotec Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Evotec Main Business Overview
11.13.5 Evotec Latest Developments
11.14 Eurofins Scientific
11.14.1 Eurofins Scientific Company Information
11.14.2 Eurofins Scientific Preclinical Toxicology Testing Service Product Offered
11.14.3 Eurofins Scientific Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Eurofins Scientific Main Business Overview
11.14.5 Eurofins Scientific Latest Developments
11.15 Pharmaron
11.15.1 Pharmaron Company Information
11.15.2 Pharmaron Preclinical Toxicology Testing Service Product Offered
11.15.3 Pharmaron Preclinical Toxicology Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Pharmaron Main Business Overview
11.15.5 Pharmaron Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
